PT  - JOURNAL ARTICLE
AU  - T Kobayashi
AU  - J Sugihara
AU  - S Harigaya
TI  - Mechanism of metabolic cleavage of a furan ring.
DP  - 1987 Nov 01
TA  - Drug Metabolism and Disposition
PG  - 877--881
VI  - 15
IP  - 6
4099  - http://dmd.aspetjournals.org/content/15/6/877.short
4100  - http://dmd.aspetjournals.org/content/15/6/877.full
SO  - Drug Metab Dispos1987 Nov 01; 15
AB  - We studied the mechanism of metabolic cleavage of a furan ring, using a new hypolipidemic agent, ethyl 2-(4-chlorophenyl)-5-(2-furyl)oxazole-4-acetate (TA-1801), as a model compound. A TA-1801 analogue labeled with deuterium at the 5-position of its furan ring was administered orally to rats. The analysis of urinary metabolites by GC/MS revealed that the deuterium of the furan was retained in the ring-opened metabolite (M3). Metabolic cleavage of furan has been generally considered to proceed by hydroxylation of the 5-position followed by tautomerism and hydrolysis of the resulting 5-hydroxyfuran derivative. However, if the cleavage proceeded by this pathway, the deuterium of the 5-position would be eliminated during hydroxylation. Therefore, we propose that the ring was cleaved directly to form an unsaturated aldehyde, considering the mechanism of oxidation by cytochrome P-450. Although this "intermediate" was not detected in the biological specimens, a synthetic unsaturated aldehyde was transformed to the actual urinary metabolites M2 and M3 (major ring-opened metabolites) in the isolated rat liver.